Meir Wetzler, MD, chief of the leukemia section and medical director of clinical services in the Department of Medicine at Roswell Park Cancer Institute in Buffalo, New York, died February 23, 2015, at the age of 60. He had been a member of the AACR since 1993. Wetzler was prominent in his field and served on the National Comprehensive Cancer Network’s Chronic Myelogenous Leukemia (CML) Treatment Committee, helping set the standard of care for CML patients.
At Roswell Park, Wetzler chaired the Pharmacy and Therapeutics Committee and co-chaired the Ambulatory Services Executive Committee. He also oversaw the leukemia tissue biorepository and managed a research laboratory, in addition to carrying a full clinical load.
Born Dec. 1, 1954, Wetzler, a native of Israel, received his medical degree from Hebrew University’s Hadassah Medical School in Jerusalem and a completed a residency in internal medicine at Kaplan Hospital in Rehovot. He joined Roswell Park in 1994 following two fellowships in clinical immunology/biologic therapy and medical oncology, respectively, at The University of Texas MD Anderson Cancer Center in Houston.